-
Variation in Living Donor Kidney Transplantation and the Impact of Medicaid Expansion
-
Variation in Racial Disparities in Liver Transplant Outcomes by Hospital Quality
-
Variations in DCD Procurement Procedures across Opos and Their Effects on Liver Transplant Outcomes
-
Variations in Recipient and Donor Clinical Characteristics between Kidney Transplant Centers
-
VCA Deceased Donor Solid Organ Yield
-
Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial Outcomes: Proteomic Analysis of Perfusates from Livers Undergoing Normothermic Machine Liver Perfusion Reveals Biomarkers Predictive of Graft Viability and Post-Transplant Complications
-
Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial: Metabolomics of Ex Vivo Normothermically Machine Perfused Livers Discloses Molecular Signatures Predictive of Graft Viability and Post Transplant Outcomes
-
Vimentin Inhibition Improves Post-Transplant Survival in a Mouse Renal Transplant Model
-
Viral Enteritis in Intestinal Transplant Recipients
-
Visceral Arterial Embolization – An Important Tool For Managing Blood Loss In Multivisceral Transplant Candidates With Portomesenteric Thrombosis
2019 American Transplant Congress
June 1-5, 2019 in Boston, MA